Tuesday, October 29, 2013

Cardiac Monitoring Market worth $23.3 Billion - 2017

The “Healthcare” practice at MarketsandMarkets is pleased to announce its Analyst Briefing Presentation on the “Cardiac Monitoring & Cardiac Rhythm Management (CRM) Market [ECG, Implantable Loop Recorder, Holter, Implantable Cardioverter Defibrillator (ICD), Automated External Defibrillator (AED), Pacemaker, CRT-D, CRT- P] - Global Forecasts to 2017” to be held on 11 February 2013

Browse:
  • 144 tables 
  • 23 figures
  • 334 pages combined with an in-depth TOC on "Cardiac Monitoring & Cardiac Rhythm Management (CRM) Market" [ECG, Implantable Loop Recorder, Holter, Implantable Cardioverter Defibrillator (ICD), Automated External Defibrillator (AED), Pacemaker, CRT-D, CRT- P] - Global Forecasts to 2017”.
http://www.marketsandmarkets.com/Market-Reports/cardiac-monitoring-advanced-technologies-and-global-market-55.html
Early buyers will receive 10% customization on this report.
To buy this report click here:

Cardiac Monitoring and Cardiac Rhythm Management Market was worth $18.4 billion in the year 2012. The market will grow at a healthy pace in the next five years due to the increasing incidence of cardiovascular diseases, technological advancement, rising cost of cardiac disease treatment, and government regulations in favor of cardiac monitoring.

The key players in the cardiac monitoring and cardiac rhythm management market are Boston Scientific (U.S.),Cardiac Science Corporation (U.S.), CardioNet (U.S.), GE Healthcare (U.K.), LifeWatch (Switzerland), Medtronic (U.S.), Mortara Instruments (U.S.), Philips Healthcare (The Netherlands), Schiller (Switzerland), Spacelabs Healthcare (U.S.), St. Jude Medical (U.S.), Welch Allyn (U.S.), and Zoll Medical Corporation (U.S.).

Increasing incidence of cardiovascular diseases, technological advancement, rising cost of cardiac disease treatment, and government regulations in favor of cardiac monitoring are accelerating the growth of conventional monitors as well as CRM devices. However, the economic slowdown and unstable reimbursement policies will hamper the growth of this market, to a certain extent.

The geographies covered in this study are North America, Europe, Asia, and Rest of the World (RoW). These four regions are further segmented by major countries, and geographic split for all the sub-segments is presented at a regional level. North America is the largest market for cardiac monitoring and cardiac rhythm management devices, followed by Europe and Asia. North America and Europe are expected to grow at a slower pace, primarily due to the economic slowdown and market maturity. The Asian market, especially India and China, is expected to witness a boost in demand for cardiac monitoring and CRM products, and is poised to register maximum growth over the next five years, owing to the rising incidence of cardiovascular diseases and increased purchasing power of patients.

@Source: MarketsandMarkets

Friday, October 11, 2013

Dental Implant & Prosthetics Market - Global orecast upto 2018 | MarketsandMarkets

The global dental implants and prosthetics market was majorly dominated by Europe in 2012. By 2018, Europe will continue to drive and dominate the dental implants and prosthetics market. The market share of this region will decrease slightly to 40.1%, primarily due to the increase in demand for dental implants and prosthetics in Asia-Pacific and in some Latin American countries. The growth of the Asian market will primarily be driven by China and India. This is mainly attributed to the rising disposable incomes, increasing focus of major players, and the ongoing development of these economies. The North American market is expected to grow at a higher pace than Europe mainly due to lower penetration and the high adoption rate of advanced dentistry

For more information download free PDF
 
http://www.marketsandmarkets.com/pdfdownload.asp?id=695

Source @ http://marketsreports.livejournal.com/3179.html

Cancer profiling Market to be driven by Increasing Applications

Uncontrolled growth and proliferation of cells leads to nonmalignant and cancerous tumors. Classification of these tumors is done with help of gene expression cancer profiling. Every growing cell of cancer has unique pattern and a combination of proteins and genes. Profiling of these patterns help the healthcare industry to perform better diagnosis and staging the prognosis. One of the most commonly used techniques is molecular biology; cancer or tumor profiling is a promising market across the globe. Global cancer profiling market is growing at a rapid rate, which is a positive sign for the components of this industry. Increasing area of application, innovative techniques and occurrences of cancer are driving the global industry at an impressive rate.

Source @ http://mnmblog.org/cancer-profiling-market.html

Wednesday, October 9, 2013

Nerve Repair Market to Grow at a Steady CAGR until 2018

Neuroregeneration is the regrowth of repairing of nervous cells and tissues. Several clinical processes are performed to repair the nerve tissues and cell products, which are predominantly included in the global nerve repair market. Increasing aging population and technological advancements in nerve regeneration market are the biggest driving factors for the industry. Different types of surgeries and treatment proceedings are used based on the parts of the system. Researchers estimate healthy growth in terms of the compound annual growth rate in the industry, which is a good sign for the overall market dynamics for nerve repair.